The rare athlete will remember that feeling and devote his/her life to sharing it with others. Rutland, Vt. resident Steve Lulek is an example of such an athlete.
Check out our gear picks for summer fun and travel like the Therm-a-Rest Comfort System to keep you cozy when you're camping.
How you can learn to control that adrenaline rush and use it to your advantage on race day.
French anti-doping authorities and Saunier Duval team officials confirmed Thursday that Italian climbing sensation Ricardo Ricco (Saunier Duval) has tested positive for the blood booster erythropoietin (EPO)
Informed of the positive just an hour before the start of Thursday’s 12th stage of the Tour de France, Ricco was taken by gendarmes to a local police station for questioning. Within minutes of Ricco’s departure, his entire team voluntarily withdrew from the Tour.
Saunier Duval director Joxean Fernandez told VeloNews that it made no sense for the team to continue.
“It’s a decision from the team; we were not forced to pull out of the Tour de France,” Fernandez said. “He is our GC leader, so logically we can not start the day and act as if nothing has happened.”
Ricco, winner of two mountain stages and ninth in the overall standings, provided a urine sample following the stage 4 time trial at Cholet, which contained metabolites of synthetic erythropoietin (rEPO) and a new substance, CERA (Continuous Erythropoiesis Receptor Activator).
Like rEPO, CERA was developed as a treatment for the anemia that results from chronic kidney disease. Unlike single injections of rEPO, CERA interacts with erythropoietin receptors and has a longer-lasting effect.
Developed by Swiss pharmaceutical giant F. Hoffman-La Roche, the drug is marketed under the brand name Micera. Available in Europe, the sale and distribution of Micera in the United States has been the subject of a long court battle between Roche and Amgen, the company that originally developed recombinant erythropoietin – originally marketed as EPOGEN – in the late 1980s.
Like synthetic erythropoietin (rEPO), CERA was developed to as a treatment for the anemia that results from chronic kidney disease. Unlike single injections of rEPO, CERA interacts with erythropoietin receptors and has a longer-lasting effect. Patients who were normally required to inject rEPO three times a week were able to achieve the same results with only one or two injections per month.
Recent rumors in the sport had suggested that some riders were using an undetectable new oxygen-enhancing drug widely thought to be Roche’s Micera. The existence of a test for CERA was not announced, but Ricco’s positive for the substance suggests that it has not escaped the attention of anti-doping officials.
If confirmed, Ricco's positive would negate both of his wins at this Tour.Photo: Graham WatsonThe often brash and outspoken Ricco finished second in this year’s Giro d’Italia and won stages six and nine at this year’s Tour de France. He finished Wednesday’s stage 2:29 behind Australian Cadel Evans in the overall standings, putting him in ninth place.
Ricco and his team arrived at the start of stage 12 on Thursday morning, unaware of the results of the Cholet test. As his teammates went to the official sign-in, Ricco and his director were given the news and the 24-year-old team leader stayed in his team truck to confer with doping officials, French gendarmes and his team director.
Moments after his teammates returned from sign-in, Ricco climbed out of his team truck and joined police in a Saunier Duval car for a trip to a local police station for further questioning. The news had spread fast and both vehicles were surrounded by scores of reporters and fans, the latter of which began hissing and booing as the rider made his way to the car.
Fernandez said he and the team were still grappling with the news and said he had no idea what team officials or sponsors would do in response to the positive.
“We are surprised and shocked,” he said. “We just found out 10 minutes ago. We are suspending all activities of the team until we can understand what happened.”
Ricco becomes the third rider to fail a doping test in this year's race after Spanish riders Moises Duenas (Barloworld) and Manuel Beltran (Liquigas) both tested positive for rEPO.
The location of Ricco’s alleged doping violation carries with it a bit of sad historical significance. It was 10 years ago in Cholet that the Festina scandal reached a crisis with the arrests of team director Bruno Roussel and team doctor Eric Rijkaert on July 15. Later that day, police searched the hotel rooms of the team and the following day, all of Festina’s riders were ejected from the Tour. The scandal eventually led to the 1999 creation of the World Anti-Doping Agency, which signaled a new hard line on the question of doping in sport.
Cycling, however, continues to struggle with the problem, as this latest example demonstrates.
VeloNews European correspondent Andrew Hood contributed to this report
| Comments |
|
